Champions Oncology
CSBR
32 hedge funds and large institutions have $47.8M invested in Champions Oncology in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
5.04% more ownership
Funds ownership: 49.36% → 54.4% (+5%)
0% more capital invested
Capital invested by funds: $47.8M → $47.8M (+$17K)
0% more funds holding
Funds holding: 32 → 32 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BPI
Battery Partners IX
Boston,
Massachusetts
|
+$2.86M |
| 2 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$1.06M |
| 3 |
CPA
Cowen Prime Advisors
New York
|
+$1.02M |
| 4 |
TAM
Tocqueville Asset Management
New York
|
+$335K |
| 5 |
GC
Globeflex Capital
San Diego,
California
|
+$163K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$175K |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$122K |
| 3 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
-$119K |
| 4 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
-$82.7K |
| 5 |
Renaissance Technologies
New York
|
-$72K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Victory Capital Management
San Antonio,
Texas
| $16K | +$14.4K | +2,054 | New |
|
|
VIMU
27
Veritas Investment Management (UK)
London,
United Kingdom
| $15K | – | – | – |
|
|
PAM
28
Panagora Asset Management
Boston,
Massachusetts
| $3K | – | – | – |
|
|
TRCT
29
Tower Research Capital (TRC)
New York
| $1K | -$11.6K | -1,665 | -90% |
|
30
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | -$440 | -63 | -37% |
|
|
31
Wells Fargo
San Francisco,
California
| – | -$175K | -24,963 | -100% |
|
32
UBS Group
Zurich,
Switzerland
| – | -$12K | -1,398 | Closed |
|
|
APC
33
Aspire Private Capital
Cornelius,
North Carolina
| – | -$2K | -200 | Closed |
|
34
Osaic Holdings
Scottsdale,
Arizona
| – | +$84 | +12 | New |
|
CSBR Hedge Fund Activity: Q1 2020 in Review
32 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Champions Oncology (CSBR) for Q1 2020, worth a combined $47.8M — up 0.04% from $47.8M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CSBR positions and 3 closed out — a net gain of 1 holder — while 10 added to existing stakes and 10 trimmed.
The largest buyer was Battery Partners IX, adding an estimated $2.86M. The largest seller was Wells Fargo, cutting an estimated $175K.
- 32 institutional investors held Champions Oncology (CSBR) as of Q1 2020, unchanged from Q4 2019.
- Funds reported $47.8M of Champions Oncology stock for Q1 2020, up 0.04% quarter-over-quarter.
- 4 funds opened new Champions Oncology positions in Q1 2020 and 3 closed out, a net change of +1 holder.
- The largest Champions Oncology buyer in Q1 2020 was Battery Partners IX, an estimated $2.86M added.
- The largest Champions Oncology seller in Q1 2020 was Wells Fargo, an estimated $175K sold.
Based on aggregated 13F filings for Q1 2020.